From Vaccines to Memory and Back

Slides:



Advertisements
Similar presentations
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Advertisements

Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus Bram Slütter, Lecia L. Pewe, Susan M. Kaech,
CMV and the Art of Memory Maintenance
Antigen-Primed CD8+ T Cells Call DCs for Back Up
Memory T Cells Officially Join the Stem Cell Club
HIV-1 Latency by Transition
An Activation Marker Finds a Function
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Vaccine Adjuvants: Putting Innate Immunity to Work
Memory: The Incomplete Unhappening of Differentiation
TCF-1 Flips the Switch on Eomes
Peter Libby, Andrew H. Lichtman, Göran K. Hansson  Immunity 
Monocyte-Plasmablast Crosstalk during Dengue
Volume 27, Issue 4, Pages (October 2007)
Some DCs Are “B”etter Immunity
Front-Line Memory T Cells Think Outside the T-box… Mostly
Chronic Infections Capture Little Attention of the Masses
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Volume 33, Issue 1, Pages (July 2010)
miR-155-SOCS1 as a Functional Axis: Satisfying the Burden of Proof
T Helper 17 Cells Get the NOD
Volume 28, Issue 5, Pages (May 2008)
The Multitasking Organ: Recent Insights into Skin Immune Function
Monocyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania  Beatriz León,
Miki Ando, Hiromitsu Nakauchi  Experimental Hematology 
Intracellular Pathogens and CD8+ Dendritic Cells: Dangerous Liaisons
Who Benefits from Granulomas, Mycobacteria or Host?
Arming Treg Cells at the Inflammatory Site
IgM Memory Cells: First Responders in Malaria
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Dwelling on T Cell Fate Decisions
Like Parent, Like Child: Inheritance of Effector CD8+ T Cell Traits
Successful and Maladaptive T Cell Aging
The Multitasking Organ: Recent Insights into Skin Immune Function
Chronic Infections Capture Little Attention of the Masses
Monocyte-Plasmablast Crosstalk during Dengue
Immune Modulation of Stem Cells and Regeneration
Thomas R. Malek, Iris Castro  Immunity 
An IL-1β-Dependent Switch in Innate Mucosal Immunity?
Turning Tumors into Vaccines: Co-opting the Innate Immune System
The Role of Retinoic Acid in Tolerance and Immunity
Natural Killer Cell Memory
Thomas S. Griffith, Thomas A. Ferguson  Immunity 
Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
Volume 24, Issue 5, Pages (May 2006)
Tissue-Resident Memory T Cells
Volume 28, Issue 5, Pages (May 2008)
Volume 35, Issue 2, Pages (August 2011)
Skin-Resident T Cells: The Ups and Downs of On Site Immunity
Biochemical Underpinnings of Immune Cell Metabolic Phenotypes
Human T Cell Development, Localization, and Function throughout Life
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Monocyte-Macrophages and T Cells in Atherosclerosis
Volume 39, Issue 1, Pages (July 2013)
Chronic Bystander Infections and Immunity to Unrelated Antigens
IL-22 from T Cells: Better Late than Never
One Bug or Another: Promiscuous T Cells Form Lifelong Memory
Inflaming the CD8+ T Cell Response
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
Volume 38, Issue 6, Pages (June 2013)
Peripheral Tolerance of CD8 T Lymphocytes
Cell-Intrinsic Barriers of T Cell-Based Immunotherapy
Development and Function of Dendritic Cell Subsets
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Keeping STATs on Memory CD8+ T Cells
VHL Brings Warburg into the Memory Spotlight
Dendritic Cells Decide CD8+ T Cell Fate
TCF-1 Flips the Switch on Eomes
Memoirs of a Reincarnated T Cell
Presentation transcript:

From Vaccines to Memory and Back Federica Sallusto, Antonio Lanzavecchia, Koichi Araki, Rafi Ahmed  Immunity  Volume 33, Issue 4, Pages 451-463 (October 2010) DOI: 10.1016/j.immuni.2010.10.008 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Using the Principles of Memory T Cell Differentiation to Determine the Optimal Time for Boosting (A) After primary vaccination, naive T cells proliferate and differentiate into effector cells. The majority of these effectors undergo apoptosis but a subset further differentiates to form the pool of long-lived memory cells. This model of progressive memory T cell differentiation is characterized by a gradual acquisition of memory T cell properties such as the ability to make effective proliferative responses upon re-encounter with antigen. (B) Based on this memory differentiation program, the optimal time for boosting is during the late stages of the effector to memory transition, and therefore an interval of 2–3 months is recommended between the prime and the boost. Immunity 2010 33, 451-463DOI: (10.1016/j.immuni.2010.10.008) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 Repeated Immunizations Drive Memory T Cells toward Terminal Differentiation: Implications for Memory Cell Heterogeneity and Protective Immunity (A) Repetitive antigen encounter results in memory T cells with more effector-like properties and with preferential location in nonlymphoid tissues but with reduced proliferative potential. (B) If all memory T cells are recruited into the response after each booster shot, then the entire pool of memory T cells would be driven toward terminal differentiation. (C) If only some of the memory T cells are activated upon subsequent booster immunizations, then one would end up with a heterogenous pool of memory T cells with both effector-like cells at mucosal sites and also memory cells with proliferative capacity. Immunity 2010 33, 451-463DOI: (10.1016/j.immuni.2010.10.008) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 Using Drugs to Modulate Memory CD8+ T Cell Differentiation (A) Antigen-specific CD8+ T cell responses after an acute infection or vaccination. During the expansion phase, naive CD8+ T cells proliferate and then become effector cells. After clearance of the pathogen, 90% to 95% of the effector T cells die during a contraction phase. The surviving 5%–10% of the antigen-specific T cells become the memory population. (B) Without rapamycin treatment. (C) Rapamycin improves both quality and quantity of memory CD8+ T cells. Rapamycin treatment increases memory precursor effector cells that survive during the contraction phase and also improves quality of memory T cells by accelerating effector to memory T cell formation. Immunity 2010 33, 451-463DOI: (10.1016/j.immuni.2010.10.008) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 The Use of High Throughput Cellular Screens to Inform Vaccine Design (A) Memory B and T cells can be isolated according to the expression of surface markers and cultured in limiting dilution conditions to assess specificity, phenotype, and function of individual cells. Specific antibodies can be retrieved by memory B cell immortalization or by amplification of the V region genes from single cells. T cell libraries can be screened in an iterative fashion to determine fine specificity and to isolate T cell clones. (B) Naive T cells stimulated in vitro with monocytes or DCs and whole pathogens recapitulate the phenotype of ex vivo isolated memory T cells. Immunity 2010 33, 451-463DOI: (10.1016/j.immuni.2010.10.008) Copyright © 2010 Elsevier Inc. Terms and Conditions